"Dr Michael Stein, MD, BNIMEG Medical Director,said:“We are extraordinarily pleased with the OrionLifeSpan™ MEGand the much-needed enhanced brain imaging capability it will allow BNI to offer our patients. We are eager to begin MEG measurements for our clinical epilepsy program, which will bring improved surgical outcomes from this debilitating disorder."
Sounds amazingly good news, I guess if they hadn't dissapointed with earlier announcements this would have put a rocket under the SP. I mean if you compare to other biotechs.. that might get approval and have huge valuations on the " might" possibility this is a great company for the longer term !
CMP Price at posting:
55.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)